Spero Therapeutics Inc
General ticker "SPRO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $60.0M
Spero Therapeutics Inc does not follow the US Stock Market performance with the rate: -26.4%.
Estimated limits based on current volatility of 2.6%: low 0.94$, high 0.99$
Short-term SPRO quotes
Long-term SPRO plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $18.26MM | $48.58MM | $96.73MM |
| Operating Expenses | $106.23MM | $90.78MM | $75.25MM |
| Operating Income | $-87.97MM | $-42.20MM | $21.48MM |
| Non-Operating Income | $2.10MM | $-4.22MM | $3.92MM |
| Interest Expense | $1.94MM | $2.60MM | $0.00MM |
| R&D Expense | $64.53MM | $47.59MM | $51.44MM |
| Income(Loss) | $-85.88MM | $-46.41MM | $25.40MM |
| Taxes | $0.00MM | $1.61MM | $2.60MM |
| Profit(Loss) | $-85.88MM | $-48.03MM | $22.81MM |
| Stockholders Equity | $88.29MM | $75.93MM | $106.89MM |
| Inventory | $0.00MM | $4.46MM | $0.00MM |
| Assets | $171.07MM | $124.80MM | $182.39MM |
| Operating Cash Flow | $-64.35MM | $-7.73MM | $-32.99MM |
| Capital expenditure | $0.04MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $7.67MM | $33.81MM | $0.00MM |
| Financing Cash Flow | $84.05MM | $-29.55MM | $0.22MM |
| Earnings Per Share* | $-2.96 | $-1.28 | $0.43 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.